HB-adMSC Allogeneic is under clinical development by Hope Biosciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

HB-adMSCs is under clinical development by Hope Biosciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Mr Quinn exclusively confirmed to this newspaper in July that he had personally secured “agreement in principle” from “a ...